Cat: IPD-X39624

Recombinant Human RNASE12 Protein,His

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • Gene name

    RNASE12

  • Application

    SPRMSTBLIITCELISACELL ASSAYDRUG SCREENING

  • Alternative Names

    Probable inactive ribonuclease-like protein 12

  • Species

    Human

  • Source

    E. coli

  • Tag

    N-His

  • Purity

    Greater than 90% as determined by SDS-PAGE.

  • Uniprot

    Q5GAN4

  • Expression Region

    Glu21~Lys147

  • Molecular Weight

    18kDa

  • Endotoxin

    < 1.0 EU per μg protein as determined by the LAL method.

  • Form

    Freeze-dried powder

  • Buffer formulation

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • Reconstitution

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • Customization

    Site-directed mutagenesis Custom tag design Custom buffer formulation Custom full-length protein production

  • Stability Test

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • Storage & Shelf Life

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • Shipping

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

RNASE12, a member of the ribonuclease A superfamily, has garnered attention due to its potential roles in various biological processes, including RNA metabolism, immune response, and the regulation of gene expression. Initially identified in humans, the RNASE12 gene encodes an enzyme that exhibits unique structural and functional properties, distinguishing it from other RNases. Studies have suggested that RNASE12 may participate in antiviral defense mechanisms, making it a candidate for investigation in the context of infectious diseases. Additionally, its evolutionary significance is underscored by its presence in multiple vertebrate lineages, hinting at a conserved function over time. Recent research endeavors have focused on the recombinant expression of RNASE12 to elucidate its enzymatic activity and substrate specificity. By producing RNASE12 in a controlled laboratory environment, scientists aim to gain insights into its biochemical properties and potential therapeutic applications. Understanding the structure-function relationship of RNASE12 could pave the way for novel strategies in treating viral infections or regulating cellular processes linked to RNase activity. Furthermore, the investigation of RNASE12's interactions with RNA molecules may reveal new dimensions of RNA biology, highlighting the enzyme's importance beyond traditional ribonuclease functions. Overall, the study of RNASE12 not only contributes to our understanding of ribonucleases but also opens avenues for research in molecular biology, biotechnology, and medicine.

E-mail

sales@ipodix.com

Sales

+1 2092920560


Contact us via WhatsApp

IPODIX Biotech Inc

2108 N ST, STE N
Sacramento, CA 95816, USA

For Product Information and Orders

sales@ipodix.com

For Business Collaboration

sales@ipodix.com

For CRO Services

sales@ipodix.com

For Technical Support

sales@ipodix.com
  • 50000+

    Recombinant Proteins

  • 100+

    Researchers

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US